Clinical Trial: A Study to Evaluate AHB-137 Injection in Treatment-naive Participants With Chronic Hepatitis B

U.S., June 10 -- ClinicalTrials.gov registry received information related to the study (NCT07635186) titled 'A Study to Evaluate AHB-137 Injection in Treatment-naive Participants With Chronic Hepatitis B' on May 28.

Brief Summary: This study is a randomized, double-blind, placebo-controlled, multicenter phase 2 study to assess the efficacy and safety of AHB-137 injection in treatment-naive participants with chronic hepatitis B.

Study Start Date: June 20

Study Type: INTERVENTIONAL

Condition: Chronic Hepatitis B

Intervention: DRUG: AHB-137

AHB-137 will be administered subcutaneously.

DRUG: Placebo

Placebo will be administered subcutaneously.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Ausper Biopharma Co., Ltd.

Published by H...